How much is Metsera worth in 2026?

Metsera has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Metsera raised?

Metsera has raised N/A in total funding across 1 funding rounds.

Metsera

Drug Discovery

Metsera valuation and funding history | Last updated: November 13, 2024 | 1 funding rounds

Current Valuation

N/A

As of November 13, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$215.0M

Last Funding

Nov 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 13, 2024	Early Stage VC (Series B)	$215.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Metsera is currently valued at N/A as of November 13, 2024.

Track Metsera Valuation Updates

Get notified when Metsera raises new funding or valuation changes

Explore More Data

Detailed analysis for Metsera

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Metsera's valuation history, funding rounds, and growth metrics.

No credit card required

What is Metsera Worth in 2026?

Metsera is a leading private company in the Drug Discovery sector. Track Metsera's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Metsera Valuation is Determined

Private company valuations like Metsera's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.